Insulet Corporation (NAS: PODD) Stock Analysis & Fundamentals

PODDInsulet Corporation

NAS · US · Healthcare · Medical Devices · insulet.com

164.43USD+3.23%Mkt Cap: 11.39B $P/E: 38.421d ago

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising …

Headline	Source	Time
This week
3 Quality Compounders on Our Buy List Quality compounders are well-oiled machines. Their competitive advantages allow them to make profits consistently and reinvest them into projects that generate even more profits, creating a virtuous cycle of returns.	StockStory	2d
Insulet Corporation (PODD) Fell Along with Broad Medtech Sector ClearBridge Investments, a global equity manager, recently published second-quarter 2026 commentary for its “SMID Cap Growth Strategy”. A copy can be downloaded here. Small and mid-cap (SMID) growth equities experienced the strongest quarter in recent memory, with the Russell 2500 Growth Index rising 24.0%, driven by enthusiasm for AI infrastructure and higher-beta momentum stocks. The […]	Insider Monkey	Jul 13
Here's How Much You'd Have If You Invested $1000 in Insulet a Decade Ago Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.	Zacks	Jul 13
Older
DXCM Grew. The Stock Did Not. Someone Is Wrong	Trefis	Jul 10
Insulet (PODD) Stock Still Trades At A Premium As Shares Fell 47%	Simply Wall St.	Jul 10
Insulet (PODD) Launches Omnipod 5 In Spain, Is The Stock Cheap?	Simply Wall St.	Jul 10
Glucotrack Clears Key Milestone to Commercialize Its Implantable CGM	Exec Edge	Jul 8
Is Insulet Corporation (PODD) Stock Still a Diabetes Device Growth Opportunity After Analyst Target Cut?	Insider Monkey	Jul 8
Insulet Broadens Omnipod 5 Presence With Commercial Launch in Spain	Zacks	Jul 8
Is it Prudent to Retain Insulet Stock in Your Portfolio for Now?	Zacks	Jul 7
Why Insulet (PODD) Could Beat Earnings Estimates Again	Zacks	Jul 7
How To Target A 10% Yield While Catching The BSX Stock Knife?	Trefis	Jul 7
Insulet launches Omnipod 5 in Spain	MedTech Dive	Jul 7
Insulet (PODD): Deutsche Bank Initiates Coverage With a Buy and a $190 Target	Insider Monkey	Jul 6
Insulet Recalls Omnipod Pods After Insulin-Delivery Failure Risk Identified, FDA Says	MT Newswires	Jul 2
Patient Monitoring Stocks Q1 Earnings Review: Insulet (NASDAQ:PODD) Shines	StockStory	Jun 30
Could Insulet’s (PODD) Russell 2500 Debut Quietly Reframe the Omnipod Investment Narrative?	Simply Wall St.	Jun 30
Insulet (PODD) Appoints Jay Mazelsky To Its Board Of Directors	Simply Wall St.	Jun 30
Do Options Traders Know Something About Insulet Stock We Don't?	Zacks	Jun 29
Insulet (PODD) Just Overtook the 50-Day Moving Average	Zacks	Jun 29
If You Invested $1000 in Insulet 10 Years Ago, This Is How Much You'd Have Now	Zacks	Jun 26
1 of Wall Street’s Favorite Stocks for Long-Term Investors and 2 We Avoid	StockStory	Jun 25
1 Mid-Cap Stock Worth Your Attention and 2 We Question	StockStory	Jun 24
Insulet (PODD): New Data Shows Its Next-Gen System Delivers Far More Automated Insulin	Insider Monkey	Jun 22
Bank of America Securities Maintains Buy Rating on Insulet (PODD) Stock	Insider Monkey	Jun 21
Insulet (PODD) Announces Positive Clinical Trial Results for Next-Generation Omnipod 6 AID System	Insider Monkey	Jun 19
Insulet Corporation Stock: Is PODD Underperforming the Healthcare Sector?	Barchart	Jun 19
If You’re Looking for the ‘Next Big Thing’ Before the OpenAI and Anthropic IPOs, Try This Barchart Stock Screener	Barchart	Jun 15
2 S&P 500 Stocks to Target This Week and 1 That Underwhelm	StockStory	Jun 15
Is Insulet Corporation (PODD) A Good Stock To Buy Now?	Insider Monkey	Jun 11
Assessing Insulet (PODD) Valuation After New Omnipod Clinical Data And System Updates	Simply Wall St.	Jun 11
Insulet (PODD) Enhances Omnipod 5 System with New Target Glucose Option	Insider Monkey	Jun 8
Why Is Insulet (PODD) Down 8.7% Since Last Earnings Report?	Zacks	Jun 5
Dexcom buys Nutrisense; Insulet rolls out patch pump update	MedTech Dive	Jun 5
Is Omnipod 5’s Algorithm and Libre 3 Plus Upgrade Altering The Investment Case For Insulet (PODD)?	Simply Wall St.	Jun 5
3 Reasons We’re Fans of Insulet (PODD)	StockStory	Jun 4
DexCom vs. Insulet: Which Diabetes Stock Is a Better Buy in 2026?	Motley Fool	Jun 4
Tandem Diabetes Valuation: Is 1.1x Sales a Buy?	Zacks	Jun 3
How The Insulet (PODD) Investment Narrative Is Evolving After Recent Developments	Simply Wall St.	Jun 3
TNDM Stock: What to Know About Tandem's 2026 Reset	Zacks	Jun 2
Insulet Corporation (PODD) Initiates Voluntary Correction For Certain Omnipod Devices	Insider Monkey	Jun 1
Court overturns Insulet’s $59M trade secret verdict against EOFlow	MedTech Dive	Jun 1
Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More	Motley Fool	May 30
Insulet Device Correction Puts Omnipod Safety And Valuation In Focus	Simply Wall St.	May 30
PODD Stock: What a Hold Rating Says at a $163 Target	Zacks	May 28
BSX Stock: Don't Try To Catch The Falling Knife	Trefis	May 28
William Blair Initiates on Insulet (PODD) With Outperform and Says the Valuation Gap Is Hard to Justify	Insider Monkey	May 27
PODD and Omnipod 5: What's Driving Insulet's 2026 Growth	Zacks	May 27
Insulet recalls 7M patch pumps due to leak risk	MedTech Dive	May 27
Beta Bionics to launch its first insulin patch pump to compete with Insulet	MedTech Dive	May 26

Industry Peers